Stocksigma LogoStocksigma Logo

Gland Pharma Schedules Institutional Investor and Analyst Meetings in Sep'26

Gland Pharma Limited announced its schedule of institutional investor and analyst interactions under SEBI LODR Regulations

Gland Pharma Schedules Institutional Investor and Analyst Meetings in Sep'26

Gland Pharma Ltd 路 Intimation 路 10 Sept 2026, 11:14 pm

Gland Pharma Schedules Institutional Investor and Analyst Meetings in Sep'26 Gland Pharma Limited announced its schedule of institutional investor and analyst interactions under SEBI LODR Regulations. The company will conduct one-on-one meetings with East Bridge Capital on 16th Sep'26, followed by sessions with IIFL Capital and Antique Broking on 17th Sep'26. Additionally, Gland Pharma is scheduled to participate in a group meeting organized by Nomura on 25th Sep'26. All scheduled interactions remain subject to change based on exigencies from either the investors, analysts, or the company.

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements